Dale O Kiesewetter Selected Research

cyclic arginine-glycine-aspartic acid peptide

9/2012	N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression.
12/2011	MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
3/2011	Rapid and simple one-step F-18 labeling of peptides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dale O Kiesewetter Research Topics

Disease

62	Neoplasms (Cancer) 01/2019 - 01/2003
10	Insulinoma 01/2019 - 10/2011
9	Neoplasm Metastasis (Metastasis) 04/2016 - 02/2009
5	Breast Neoplasms (Breast Cancer) 06/2012 - 09/2008
4	Inflammation (Inflammations) 10/2014 - 04/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 10/2012
2	Pain (Aches) 09/2018 - 04/2011
2	Carcinoma (Carcinomatosis) 04/2016 - 11/2015
2	Stroke (Strokes) 10/2014 - 01/2002
2	Neuroinflammatory Diseases 10/2014 - 07/2014
2	Glioblastoma (Glioblastoma Multiforme) 08/2014 - 02/2014
2	Myocardial Infarction 07/2014 - 04/2012
2	Pheochromocytoma 02/2012 - 02/2011
2	Alzheimer Disease (Alzheimer's Disease) 11/2003 - 09/2003
1	Hyperthermia 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Starvation 01/2019
1	Painful Neuropathy 09/2018
1	Neuralgia (Stump Neuralgia) 09/2018
1	Anhedonia 09/2018
1	Chronic Pain 09/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 11/2017

Drug/Important Bio-Agent (IBA)

13	Peptides (Polypeptides)IBA 01/2019 - 11/2010
9	IntegrinsIBA 01/2017 - 03/2011
9	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2017 - 12/2011
6	Exenatide (Byetta)FDA Link 01/2019 - 01/2012
6	Pharmaceutical PreparationsIBA 01/2019 - 11/2005
6	Chemokine ReceptorsIBA 02/2016 - 02/2009
6	Proteins (Proteins, Gene)FDA Link 02/2016 - 01/2012
5	Glucagon-Like Peptide-1 ReceptorIBA 01/2019 - 01/2012
5	AlbuminsIBA 01/2018 - 07/2014
4	Evans Blue (Blue, Evans)FDA Link 01/2018 - 01/2016
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 12/2012
4	arginyl-glycyl-aspartic acidIBA 08/2014 - 09/2012
4	LigandsIBA 07/2014 - 11/2010
3	AntigensIBA 01/2019 - 01/2018
3	ProdrugsIBA 01/2019 - 01/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 11/2005
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2018 - 01/2012
3	Radioisotopes (Radionuclides)IBA 01/2018 - 01/2018
3	GoldIBA 01/2017 - 08/2014
3	68Ga-NOTA-exendin-4IBA 05/2016 - 03/2015
3	Sulfhydryl Compounds (Thiols)IBA 10/2015 - 07/2013
3	cyclic arginine-glycine-aspartic acid peptideIBA 09/2012 - 03/2011
3	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2012 - 10/2011
3	Epidermal Growth Factor (EGF)IBA 02/2012 - 05/2008
2	2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA 01/2019 - 01/2014
2	RadiopharmaceuticalsIBA 01/2018 - 01/2003
2	Monoclonal AntibodiesIBA 11/2017 - 09/2008
2	Small Interfering RNA (siRNA)IBA 01/2017 - 01/2012
2	zinc(II) dipicolylamineIBA 01/2017 - 01/2012
2	Matrix Metalloproteinases (MMPs)IBA 11/2014 - 02/2014
2	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 10/2014 - 07/2014
2	plerixafor FDA Link 10/2014 - 02/2012
2	Chelating AgentsIBA 08/2014 - 12/2011
2	TurpentineIBA 07/2014 - 01/2014
2	alfatide IIIBA 01/2014 - 04/2012
2	ErbB Receptors (EGF Receptor)IBA 02/2012 - 07/2009
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 02/2012 - 02/2011
2	FP-TZTPIBA 07/2006 - 11/2003
2	Cholinergic Agents (Cholinergics)IBA 07/2006 - 09/2003
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2005 - 08/2003
1	BilirubinIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	VaccinesIBA 01/2019
1	Tirapazamine (SR 4233)IBA 01/2019
1	Glucose OxidaseIBA 01/2019
1	AminesIBA 01/2019
1	Opioid Analgesics (Opioids)IBA 09/2018
1	Opioid Receptors (Opioid Receptor)IBA 09/2018
1	salicylhydroxamic acid (SHAM)IBA 09/2018
1	Sucrose (Saccharose)IBA 09/2018
1	PSMA-617IBA 01/2018
1	177Lu-EB-PSMA-617IBA 01/2018
1	peptide AIBA 01/2018
1	AcidsIBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Serum AlbuminIBA 01/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	EphA2 ReceptorIBA 11/2017
1	Immunoconjugates (Immunoconjugate)IBA 11/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2017
1	Erythropoietin FDA Link 11/2017
1	Coloring Agents (Dyes)IBA 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	AS 8IBA 01/2017

Therapy/Procedure

19	Therapeutics 01/2019 - 05/2008
5	Drug Therapy (Chemotherapy) 01/2019 - 11/2005
4	Intravenous Injections 01/2019 - 10/2011
4	Aftercare (After-Treatment) 01/2017 - 02/2011
3	Radiotherapy 01/2019 - 01/2017
3	Precision Medicine 01/2017 - 02/2014
2	Photothermal Therapy 01/2017 - 08/2014
2	Photochemotherapy (Photodynamic Therapy) 01/2016 - 01/2014
1	Immunotherapy 01/2019
1	Lasers (Laser) 01/2019